Ad
related to: famotidine and gynecomastia treatment
Search results
Results From The WOW.Com Content Network
In addition, gynecomastia occurred in 0.1% to 0.5% of men treated for non-hypersecretory conditions with cimetidine for 1 month or longer and in about 2% of men treated for pathologic hypersecretory conditions; in even fewer men, cimetidine may also cause loss of libido, and impotence, all of which are reversible upon discontinuation. [9]
Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease , gastroesophageal reflux disease , and Zollinger-Ellison syndrome . [ 4 ]
Gynecomastia can respond well to medical treatment although it is usually only effective when done within the first two years after the start of male breast enlargement. [7] Selective estrogen receptor modulators (SERMs) such as tamoxifen , raloxifene , and clomifene may be beneficial in the treatment of gynecomastia but are not approved by the ...
In 2023, 23,831 gynecomastia surgeries, reducing breast tissue for men, were performed in the U.S. Experts explain the rise in this procedure and the effect of increasing consciousness of body ...
Adipomastia, also known colloquially as fatty breasts, [2] is a condition defined as an excess of skin and/or a flat layer of adipose tissue (that doesn't protude like female breasts) in the breasts without true gynecomastia. [1] [3] [4] It is commonly present in men with obesity, and is particularly apparent in men who have undergone massive ...
Because of its hormonal effects, cimetidine rarely may cause sexual dysfunction including loss of libido and erectile dysfunction and gynecomastia (0.1–0.2%) in males during long-term treatment. [16] [17] [18] Rarely, interstitial nephritis, urticaria, and angioedema have been reported with cimetidine treatment. [16]
Peptic ulcer disease including after endoscopic treatment for bleeding [11] As part of Helicobacter pylori eradication therapy [ 12 ] Gastroesophageal reflux disease (GERD or GORD) including symptomatic endoscopy-negative reflux disease [ 13 ] and associated laryngopharyngeal reflux causing laryngitis [ 14 ] and chronic cough [ 15 ]
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.